Geospatial and Temporal Assessment of Tuberculosis Incidence in Iran - Scorecard - MDSpire

Geospatial and Temporal Assessment of Tuberculosis Incidence in Iran

  • By

  • Behnam Khodadoust

  • Fatemeh Sarvi

  • Shahnaz Rimaz

  • Mahmoud Khodadost

  • Mahshid Nasehi

  • February 9, 2026

  • 0 min

Share

Clinical Scorecard: Geospatial and Temporal Assessment of Tuberculosis Incidence in Iran

At a Glance

CategoryDetail
Condition
Key MechanismsTransmission influenced by migration, socioeconomic factors (e.g., poverty, overcrowding), and healthcare access challenges.
Target Population
Care Setting

Key Highlights

  • Add a highlight on the impact of drug-resistant TB strains and co-infections on treatment outcomes.

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement targeted public health interventions based on localized TB data.
    • Utilize Directly Observed Therapy Short-Course (DOTS) for treatment adherence.
    • Follow specific WHO guidelines for TB management.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Emphasis on adherence to treatment protocols, addressing co-infections, and specific management strategies.

        Clinical Best Practices

        • Implement localized, evidence-based interventions for TB control.
        • Enhance access to healthcare services in rural and underserved areas.
        • Utilize spatial epidemiology for informed public health decision-making.
        • Engage communities in TB awareness and prevention efforts.

        References

        Original Source(s)

        Related Content